← Leaderboards
Russell L Delude
University Of Pittsburgh At Pittsburgh
$1,453,206
Attributed
$1,453,206
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $330K · FY2006–07$500K$375K$250K$125K$0
'06
'07
Funding mix
By agency
NIH$1,453,206 · 3
By mechanism
R01$1,453,206 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- David J Hackam$18,393,277
- Henri R Ford$5,201,366
- Mitchell P. Fink$4,119,798
- Cristian Apetrei$24,938,676
- Lee H. Harrison$19,820,888
Others in their field
Top investigators on “Adenosine Triphosphate”
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
- Daria Mochly-Rosen · Stanford University$5,901,450
- Wei Chen · University Of Minnesota Twin Cities$5,857,541
- Martin J Kushmerick · University Of Washington$4,890,348
Research focus
Adenosine TriphosphateAdp RibosylationBacterial DiseaseCell LineCytokineCytoskeletal ProteinsEndotoxinsEnzyme ActivityGastrointestinal Absorption /TransportGastrointestinal EpitheliumGastrointestinal FunctionGene TargetingGenetically Modified AnimalsGenetic RegulationGenetic TranscriptionInflammatory Bowel DiseasesIntestinal MucosaLaboratory MouseLaboratory RatMitochondriaMolecular DynamicsNitric OxideNitric Oxide SynthasePhosphorylation
Grant awards (5)
Intestinal Perfusion and Permeability in Sepsis$330,027
R01 · FY2007 · GM · contact PI
Ethyl Pyruvate: A Novel Treatment for Sepsis$311,527
R01 · FY2006 · GM · contact PI
MOLECULAR MECHANISMS OF GUT BARRIER DYSFUNCTION$277,576
R01 · FY2002 · GM
MOLECULAR MECHANISMS OF GUT BARRIER DYSFUNCTION$270,608
R01 · FY2001 · GM
MOLECULAR MECHANISMS OF GUT BARRIER DYSFUNCTION$263,468
R01 · FY2000 · GM